Deciphera20Pharmaceuticals2C20Inc.  (DCPH) - NASDAQGS   Revenue / EPS Summary *      Fiscal Quarter 2020 (Fiscal Year) 2019 (Fiscal Year) 2018 (Fiscal Year) March          Revenue $62,000 $0 $0    EPS -1.36 (3/31/2020) -1.25 (3/31/2019) -0.66 (3/31/2018)    Dividends N/A N/A N/A June          Revenue $7,090(t) $25,000(t) $0    EPS -1.2 (6/30/2020) -0.56 (6/30/2019) -0.64 (6/30/2018)    Dividends N/A N/A N/A September          Revenue $15,449(t) $0 $0    EPS -1.12 (9/30/2020) -1.31 (9/30/2019) -0.65 (9/30/2018)    Dividends N/A N/A N/A December  (FYE)          Revenue $19,486(t) $0 $0    EPS -1.1 (12/31/2020) -1.36 (12/31/2019) -0.87 (12/31/2018)    Dividends N/A N/A N/A Totals          Revenue $42,087(t) $25,000(t) N/A    EPS -4.78 -4.48 -2.82    Dividends N/A N/A N/A Next 3 Years    Previous 3 Years
©2024, EDGAR®Online LLC, a subsidiary of OTC Markets Group. EDGAR® and SEC® are trademarks of the U.S. Securities and Exchange Commission. OTC Markets Group Inc.'s products and services are not affiliated with or approved by the U.S. Securities and Exchange Commission.